Literature DB >> 24647823

The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.

Hyun Jung Koo1, Hyuck Jae Choi, Hwa Jung Kim, Sun-Ok Kim, Kyoung-Sik Cho.   

Abstract

OBJECTIVES: To investigate the diagnostic performance of 15-min delayed contrast-enhanced computed tomography (15-DECT) compared with that of chemical shift magnetic resonance (CSMR) imaging in differentiating hyperattenuating adrenal masses and to perform subgroup analysis in underlying malignancy and non-malignancy.
METHODS: This study included 478 adrenal masses in 453 patients examined with 15-DECT and 235 masses in 217 patients examined with CSMR. Relative percentage washout (RPW) and absolute percentage washout (APW) on 15-DECT, and signal intensity index (SII) and adrenal-to-spleen ratio (ASR) on CSMR were measured. Sensitivity, specificity and accuracy of 15-DECT and CSMR were analysed for characterisation of adrenal adenoma. Subgroup analyses were performed in patients with and without underlying malignancy. Attenuation and size of the masses on unenhanced CT correlated with the risk of non-adenoma.
RESULTS: RPW calculated from 15-DECT showed the highest diagnostic performance for characterising hyperattenuating adrenal masses regardless of underlying malignancy, and the sensitivity, specificity and accuracy were 91.7 %, 74.8 % and 88.1 %, respectively in all patients. The risk of non-adenoma increased approximately threefold as mass size increased 1 cm or as its attenuation value increased by 10 Hounsfield units.
CONCLUSIONS: 15-DECT was more accurate than CSMR in characterising hyperattenuating adrenal masses regardless of underlying malignancy. KEY POINTS: Delayed contrast-enhanced CT and chemical shift magnetic resonance (CSMR) characterise adrenal lesions. 15-min DECT is more accurate than CSMR in characterising hyperattenuating adrenal masses. Sensitivity of CSMR decreases as the CT attenuation of adenomas increases. Risk of non-adenoma is increased 2.9-fold as size increased by 1 cm. Risk of non-adenoma is increased 2.9-fold as attenuation increased by 10 HU.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647823     DOI: 10.1007/s00330-013-3084-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.

Authors:  Fumito Fujiyoshi; Masayuki Nakajo; Yoshihiko Fukukura; Shinsaku Tsuchimochi
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

Review 2.  Adrenal imaging.

Authors:  Michael A Blake; Carmel G Cronin; Giles W Boland
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences.

Authors:  E K Outwater; E S Siegelman; A B Huang; B A Birnbaum
Journal:  Radiology       Date:  1996-09       Impact factor: 11.105

4.  Adrenal masses in oncologic patients: functional and morphologic evaluation.

Authors:  I R Francis; A Smid; M D Gross; B Shapiro; B Naylor; G M Glazer
Journal:  Radiology       Date:  1988-02       Impact factor: 11.105

5.  Adrenal gland: MR imaging.

Authors:  J P McGahan
Journal:  Radiology       Date:  1988-01       Impact factor: 11.105

6.  Cohort study of patients with adrenal lesions discovered incidentally.

Authors:  A Muth; L Hammarstedt; M Hellström; H Á Sigurjónsdóttir; E Almqvist; B Wängberg
Journal:  Br J Surg       Date:  2011-05-27       Impact factor: 6.939

7.  Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort.

Authors:  Minal J Sangwaiya; Giles W L Boland; Carmel G Cronin; Michael A Blake; Elkan F Halpern; Peter F Hahn
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

8.  Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.

Authors:  Youn Ah Choi; Chan Kyo Kim; Byung Kwan Park; Bohyun Kim
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

9.  Fine-needle aspiration biopsy of adrenal masses in patients with extraadrenal malignancy.

Authors:  A G Candel; P Gattuso; C V Reyes; R A Prinz; M J Castelli
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

10.  Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.

Authors:  Byung Kwan Park; Chan Kyo Kim; Bohyun Kim; Jung Hee Lee
Journal:  Radiology       Date:  2007-06       Impact factor: 11.105

View more
  7 in total

Review 1.  Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.

Authors:  Jung Jae Park; Byung Kwan Park; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2016-03-02       Impact factor: 3.039

Review 2.  Clinical utility of quantitative imaging.

Authors:  Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Rathan M Subramaniam; Leon Lenchik
Journal:  Acad Radiol       Date:  2014-10-22       Impact factor: 3.173

3.  Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas.

Authors:  Wendy Tu; Jorge Abreu-Gomez; Amar Udare; Abdulmohsen Alrashed; Nicola Schieda
Journal:  Radiol Imaging Cancer       Date:  2020-10-30

4.  Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors.

Authors:  Shengze Jin; Huangqi Zhang; Wenting Pan; Jiawen Yang; Binhao Zhang; Xue Dong; Xin Li; Xiuli Wu; Wenbin Ji
Journal:  Abdom Radiol (NY)       Date:  2022-07-01

5.  Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.

Authors:  Wendy Tu; Rosalind Gerson; Jorge Abreu-Gomez; Amar Udare; Rachel Mcphedran; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-06-12

6.  Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography.

Authors:  Xifu Wang; Kangan Li; Haoran Sun; Jinglong Zhao; Linfeng Zheng; Zhuoli Zhang; Renju Bai; Guixiang Zhang
Journal:  Onco Targets Ther       Date:  2016-11-03       Impact factor: 4.147

7.  Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.

Authors:  Lixiu Cao; Wengui Xu
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.